62% of large employers now cover GLP-1s, and 74% plan to expand. But widespread access hasn't delivered widespread results. The issue isn't coverage, it's execution. Rightway Chief Pharmacy Officer Kristin Devlin and Co-Founder and Chief Medical Officer Dr. Ted Feldman break down why most GLP-1 strategies underperform, where programs fall short across adherence and clinical oversight, and what high-performing employers do differently to turn GLP-1 spend into measurable outcomes.